Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04389918 · ClinicalTrials.gov registry record · NA
Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04389918: Completed NA study, sponsored by Stanford University.
NCT04389918 is a NA study that has completed, run by Stanford University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04389918, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will find out if a meal replacement of this type is satisfying and tolerable for men with prostate cancer. Participants will receive meal replacements of TalityTM as their expected sole source of nutrition for 4 weeks. The purpose of the study is to test whether TalityTM Synthetic Meal Replacements are suitable to be used in larger studies of patients with prostate or other types of cancer.
Interventions
- OTHER Tality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2024-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04389918
The ClinicalTrials.gov registry entry for NCT04389918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tality is the first listed.
NCT04389918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04389918 about?
NCT04389918 is a clinical study titled "Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer". This study will find out if a meal replacement of this type is satisfying and tolerable for men with prostate cancer. Participants will receive meal replacements of TalityTM as their expected sole source of nutrition for 4 weeks. The purpose of the study is to test whether TalityTM Synthetic Meal Re...
What is the current status of trial NCT04389918?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-10-26. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT04389918?
The interventions under investigation include: Tality (OTHER).
Who is sponsoring clinical trial NCT04389918?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.